ABSTRACT
Methamphetamine (MA) is one of the most virulent illicit drugs that can be synthesized from household materials leading to its prevalent trafficking and local manufacturing in clandestine drug laboratories (clan labs). The significant problems of tracing MA in clan labs and monitoring drug abusers lie in the lag time between sample collection and analysis and the number of tests done. Capillary electrophoresis (CE) is a rapid separation technique amenable to miniaturization and field testing. Herein, we developed a simple transient isotachophoretic (tITP)-CE method to detect MA and its precursor pseudoephedrine (PSE) in clan labs and non-invasive biological fluids. The method was implemented on the ETD-100, a commercial fully automated portable CE instrument with an integrated swab-based extraction system. Within 2 min of insertion of the swab, MA and PSE were automatically extracted with a leading electrolyte (LE) and then separated on covalently modified capillaries. The ETD-100 showed a limit of detection (LOD) and quantification (LOQ) of MA 0.02 and 0.05 µg/swab and 0.02 and 0.06 µg/swab of PSE, with an enhancement factor of 118 and 328, respectively, when compared to a normal non-tITP injection. The intra and inter-day relative standard deviation in terms of migration time were in the range of 0.75-1.93 % for both MA and PSE and were 2.0-2.4 % for both MA and PSE peak height. The method was demonstrated with the detection of spiked MA and PSE on different household materials as well as in non-invasive biological fluids with a recovery above 60 %.
Subject(s)
Electrophoresis, Capillary , Methamphetamine , Methamphetamine/analysis , Methamphetamine/isolation & purification , Electrophoresis, Capillary/methods , Humans , Limit of Detection , Pseudoephedrine/analysis , Pseudoephedrine/isolation & purification , Substance Abuse Detection/methods , Substance Abuse Detection/instrumentation , Illicit Drugs/analysis , Illicit Drugs/isolation & purificationABSTRACT
In this manuscript, a 3D-printed analytical device has been successfully developed to classify illicit drugs using smartphone-based colorimetry. Representative compounds of different families, including cocaine, 3,4-methylenedioxy-methamphetamine (MDMA), amphetamine and cathinone derivatives, pyrrolidine cathinones, and 3,4-methylenedioxy cathinones, have been analyzed and classified after appropriate reaction with Marquis, gallic acid, sulfuric acid, Simon and Scott reagents. A picture of the colored products was acquired using a smartphone, and the corrected RGB values were used as input data in the chemometric treatment. ANN using two active layers of nodes (6 nodes in layer 1 and 2 nodes in layer 2) with a sigmoidal transfer function and a minimum strict threshold of 0.50 identified illicit drug samples with a sensitivity higher than 83.4 % and a specificity of 100 % with limits of detection in the microgram range. The 3D printed device can operate connected to a rechargeable lithium-ion cell portable battery, is inexpensive, and requires minimal training. The analytical device has been able to discriminate the analyzed psychoactive substances from cutting and mixing agents, being a useful tool for law enforcement agents to use as a screening method.
Subject(s)
Illicit Drugs , Neural Networks, Computer , Printing, Three-Dimensional , Smartphone , Illicit Drugs/analysis , Colorimetry/instrumentation , Colorimetry/methods , Substance Abuse Detection/methods , Substance Abuse Detection/instrumentation , HumansABSTRACT
OBJECTIVES: Smartphones have become everyday objects on which the accumulation of fingerprints is significant. In addition, a large proportion of the population regularly uses a smartphone, especially younger people. The objective of this study was to evaluate smartphones as a new matrix for toxico-epidemiology. METHODS: This study was conducted during two separate events (techno and trance) at an electronic music nightclub in Grenoble, France. Data on reported drug use and whether drugs were snorted directly from the surface of the smartphone were collected using an anonymous questionnaire completed voluntarily by drug users. Then, a dry swab was rubbed for 20â¯s on all sides of the smartphone. The extract was analyzed by liquid chromatography coupled to tandem mass spectrometry on a Xevo TQ-XS system (Waters). RESULTS: In total, 122 swabs from 122 drug users were collected. The three main drugs identified were MDMA (n=83), cocaine (n=59), and THC (n=51). Based on declarative data, sensitivity ranged from 73 to 97.2â¯% and specificity from 71.8 to 88.1â¯% for MDMA, cocaine, and THC. Other substances were identified such as cocaine adulterants, ketamine, amphetamine, LSD, methamphetamine, CBD, DMT, heroin, mescaline, and several NPS. Numerous medications were also identified, such as antidepressants, anxiolytics, hypnotics, and painkillers. Different use patterns were identified between the two events. CONCLUSIONS: This proof-of-concept study on 122 subjects shows that smartphone swab analysis could provide a useful and complementary tool for drug testing, especially for harm-reduction programs and toxico-epidemiolgy studies, with acceptable test performance, despite declarative data.
Subject(s)
Smartphone , Humans , Substance Abuse Detection/methods , Substance Abuse Detection/instrumentation , Adult , Male , Female , Tandem Mass Spectrometry/methods , Young Adult , Chromatography, Liquid/methods , Middle Aged , Proof of Concept Study , Illicit Drugs/analysisABSTRACT
Illicit drugs are harmful substances, threatening both health and safety of societies in all corners of the world. Several policies have been developed over time to deal with this illicit drug problem, including supply reduction and harm reduction policies. Both policies require on-site detection tools to succeed, i.e. sensors that can identify illicit drugs in samples at the point-of-care. Electrochemical sensors are highly suited for this task, due to their short analysis times, low cost, high accuracy, portability and orthogonality with current technologies. In this chapter, we evaluate the latest trend in electrochemical sensing of illicit drugs, with a focus on detection of illicit drugs in seizures and body fluids. Furthermore, we will also provide an outlook on the potential of electrochemistry in wearable sensors for this purpose.
Subject(s)
Electrochemical Techniques , Illicit Drugs , Substance Abuse Detection , Illicit Drugs/analysis , Humans , Substance Abuse Detection/methods , Substance Abuse Detection/instrumentation , Electrochemical Techniques/methods , Electrochemical Techniques/instrumentation , Biosensing Techniques/methods , Biosensing Techniques/instrumentation , Wearable Electronic DevicesABSTRACT
Abstract Cannabis sativa L. is one of the most consumed drugs in the world and recent studies have associated its use with an increase in the number of traffic accidents in different countries. In many countries, like Brazil, simple and reliable methodologies are still needed for the detection of drugs on site, mainly cannabinoids, considering its prevalence of use and oral fluid (OF) has been proved as an appropriate biological matrix for this purpose. Considering that, this work aims to review previous studies on immunochromatographic devices for on-site detection of cannabinoids in OF, discussing their sensitivity, specificity, cut-offs values and confirmatory methods. This data shows the importance of choosing a screening device and it reinforces the need for its implementation in Brazil. The research was conducted on 5 databases and all original articles, published in the last 10 years, were selected. A total of 32 articles were found, providing data for 17 screening devices of distinct brands. Only 2 screening devices showed satisfactory sensitivity and specificity in the evaluated studies (≥80% and ≥90% respectively). However, it should be considered that the screening devices still have some limitations, such as a higher cut-off than those recommended by international guidelines (cut-off > 2 ng/mL), therefore demonstrating the need for more studies in the area and the importance of confirmatory analysis usually fulfilled by LC-MS/MS, GC-MS/MS or GC-MS. Thus, the screening analyzes should not be evaluated by itself, but in association with confirmatory results and observational traits (behavioral changes), for a better understanding of the traffic scenario
Subject(s)
Cannabinoids/analysis , Triage/classification , Chromatography, Affinity/instrumentation , Dronabinol/agonists , Cannabis/adverse effects , Accidents, Traffic/prevention & control , Substance Abuse Detection/instrumentationABSTRACT
Synthetic cannabinoids are one of the many substances of abuse widely spreading in modern society. Medical practitioners and law enforcement alike highly seek portable, efficient, and reliable tools for on-site detection and diagnostics. Here, we propose a colorimetric lateral flow assay (LFA) combined with dye-loaded polymersome to detect the synthetic cannabinoid JWH-073 efficiently. Rhodamine B-loaded polymersome was conjugated to antibodies and fully characterized. Two LFA were proposed (sandwich and competitive), showing a high level of sensitivity with a limit of detection (LOD) reaching 0.53 and 0.31 ng/mL, respectively. The competitive assay was further analyzed by fluorescence, where the LOD reached 0.16 ng/mL. The application of the LFA over spiked synthetic saliva or real human saliva demonstrated an overall response of 94% for the sandwich assay and 97% for the competitive LFA. The selectivity of the system was assessed in the presence of various interferents. The analytical performance of the LFA system showed a coefficient of variation below 6%. The current LFA system appears as a plausible system for non-invasive detection of substance abuse and shows promise for synthetic cannabinoid on-site sensing.
Subject(s)
Cannabinoids/analysis , Fluorescent Dyes/chemistry , Polyesters/chemistry , Polyethylene Glycols/chemistry , Rhodamines/chemistry , Substance Abuse Detection/methods , Antibodies, Immobilized/immunology , Cannabinoids/immunology , Colorimetry/instrumentation , Colorimetry/methods , Humans , Illicit Drugs/analysis , Illicit Drugs/immunology , Immunoassay/instrumentation , Immunoassay/methods , Indoles/analysis , Indoles/immunology , Limit of Detection , Naphthalenes/analysis , Naphthalenes/immunology , Paper , Reproducibility of Results , Saliva/chemistry , Substance Abuse Detection/instrumentationABSTRACT
The purpose of this review is to present an overview of roadside drug testing, driving enforcement, and drunk/drug driving detection around the world. Drunk and drug driving is a severe problem, not only in the UAE, but also around the world. This has important implications for road safety as drunk or drug driving may increase the chances of a driver's involvement in a road crash when compared to a drug-free driver. Recently, due to increases in drug-impaired drivers' crash involvement, many mobile roadside drug testing devices have been introduced to the market. These devices use oral fluid, urine or blood matrices. These are on-the-spot tests, which are easy to use and are applied by law enforcement agencies and the public. Law enforcement agencies most commonly use oral fluid to detect the presence of illicit drugs in drivers. This review discusses all the available devices in the market used by the authorities. It also describes the type of drugs widely abused by drivers along with behavioral testing methods. The different types of matrices used for roadside drug testing are also evaluated. Sample collection, storage, and pre-treatment methods are discussed, followed by the confirmatory analysis of positive samples. This article will significantly help law enforcement agencies compare and evaluate all the reliable roadside testing devices and new emerging confirmatory devices available to them in the market. This will help them make an informed decision on which device to adapt to their individual needs.
Subject(s)
Alcoholic Intoxication/diagnosis , Illicit Drugs/analysis , Point-of-Care Testing , Saliva/metabolism , Substance Abuse Detection/instrumentation , Substance Abuse Detection/methods , Accidents, Traffic/prevention & control , Automobile Driving/legislation & jurisprudence , Driving Under the Influence/legislation & jurisprudence , Humans , Illicit Drugs/adverse effects , Law Enforcement , Pharmaceutical Preparations/analysisABSTRACT
Flunitrazepam is one of the frequently used hypnotic drugs to incapacitate victims for sexual assault. Appropriate diagnostic tools should be available to victims regarding the growing concern about "date-rape drugs" and their adverse impact on society. Miniaturized screen-printed potentiometric sensors offer crucial point-of-care devices that alleviate this serious problem. In this study, all solid-state screen-printed potentiometric flunitrazepam sensors have been designed. The paper device was printed with silver and carbon ink. Formation of an aqueous layer in the interface between carbon-conducting material and ion-sensing membrane nevertheless poses low reproducibility in the solid-contact electrodes. Accordingly, poly(3,4-ethylenedioxythiophene) (PEDT) nano-dispersion was applied as a conducting hydrophobic polymer on the electrode surface to curb water accumulation. Conditioning of ion-sensing membrane in the vicinity of reference membrane has been considered carefully using special protocol. Electrochemical characteristics of the proposed PEDT-based sensor were calculated and compared favorably to PEDT-free one. The miniaturized device was successfully used for the determination of flunitrazepam in carbonated soft drinks, energy drink, and malt beverage. Statistical comparison between the proposed sensor and official method revealed no significant difference. Nevertheless, the proposed sensor provides simple and user-friendly diagnostic tool with less equipment for on-site determination of flunitrazepam.
Subject(s)
Electrochemical Techniques/methods , Flunitrazepam/analysis , Food Contamination/analysis , Hypnotics and Sedatives/analysis , Substance Abuse Detection/methods , Bridged Bicyclo Compounds, Heterocyclic/chemistry , Carbon/chemistry , Carbonated Beverages/analysis , Electrochemical Techniques/instrumentation , Energy Drinks/analysis , Ink , Paper , Point-of-Care Testing , Polymers/chemistry , Silver/chemistry , Substance Abuse Detection/instrumentationABSTRACT
The EvidenzerIRL instrument has been in use as an evidential breath analyser in the application of drink driving laws in the Republic of Ireland since 2011. The result of the analysis is used as evidence in prosecutions before the Courts in per se offences of driving under the influence of alcohol as distinct from screening results at the roadside. This study aims to assist doctors, lawyers and judges in assessing drivers' failure to provide valid evidential breath specimens. Since the introduction of the EvidenzerIRL, approximately 10% of evidential breath tests annually result in failure or refusal to provide a successful breath specimen, this is an offence under Irish road traffic laws. The presence of lung disease has been given as a reason for the driver failing to provide evidential breath specimens. The aim of this study is to assess the ability of subjects with lung disease to provide breath specimens using the EvidenzerIRL. Pulmonary function tests (PFT) were carried out on volunteers from outpatients of the pulmonary laboratory in St Vincent's University Hospital, Dublin (n = 58) and a control group with no underlying lung disease (n = 19). After the PFTs all volunteers were asked to provide breath specimens using the EvidenzerIRL. Fourteen (24%) out of 58 lung disease volunteers failed to provide a breath specimen, no one from the control group was unsuccessful. Thirteen females and one male volunteer could not successfully provide. Female volunteers were more likely to fail to provide than male volunteers. A significant difference was found between the median age of successful (62.2 years) and unsuccessful (69.2 years) lung disease volunteers. Only one PFT, percentage predicted of Forced Expiratory Volume in 1 second (FEV1), had a significant difference between the mean of successful (86.6%) and unsuccessful (66.5%) lung disease volunteers. A subject with lung disease was more likely to be successful than unsuccessful. Drivers' effort and operators' guidance through the process were found to be crucial parts to a successful outcome.
Subject(s)
Breath Tests/instrumentation , Driving Under the Influence , Lung Diseases/complications , Aged , Case-Control Studies , Central Nervous System Depressants/analysis , Ethanol/analysis , Female , Humans , Male , Middle Aged , Respiratory Function Tests , Substance Abuse Detection/instrumentationABSTRACT
INTRODUCTION: The aim of this study was to evaluate the analytical performance of the Kite Biotechnology Oral fluid (OF) screening test device, which is used for roadside screening of cannabis, opiates, amphetamines, methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), cocaine and benzodiazepines by comparing samples with matched plasma samples, analysed via liquid chromatography-tandem mass spectrometry (LC-MS/MS) for confirmation. METHODS: OF and plasma samples were obtained simultaneously from a total of 100 subjects. OF samples were analysed by OF screening test based on immunochromatography. The OF screening test cut-off values were 50 ng/mL for amphetamines (d-amphetamine) and methamphetamine/MDMA (d-methamphetamine), 30 ng/mL for cocaine (benzoylecgonine), 40 ng/mL for opiates (morphine), 20 ng/mL for benzodiazepines (nordazepam), and 25 ng/mL for cannabis (Δ9-tetrahydrocannabinol). LC-MS/MS method validation was performed according to the CLSI C62-A recommendations with the following parameters: matrix effect, lower limit of quantification (LLOQ), linearity, intra-day and inter-day precision and accuracy. RESULTS: The overall specificity, accuracy and negative predictive values (NPV) were acceptable and met the DRUID standard of >80%. The OF screening test device showed good sensitivity for cocaine, amphetamines and opiates, whereas it indicated poor sensitivity for methamphetamine/MDMA (66.7%) and failed to detect cannabis and benzodiazepines. CONCLUSION: The present study is the first report to evaluate the Kite Biotechnology OF screening test device. The diagnostic performance of the OF screening test device was acceptable for opiates, cocaine and amphetamines, but it was insufficient for methamphetamine/MDMA, benzodiazepines and cannabis because of sensitivity issues.
Subject(s)
Immunoassay/instrumentation , Immunoassay/methods , Saliva/chemistry , Substance Abuse Detection/instrumentation , Substance Abuse Detection/methods , Amphetamines/analysis , Cocaine/analogs & derivatives , Cocaine/analysis , Data Accuracy , Driving Under the Influence , Dronabinol/analysis , Equipment Failure Analysis , Female , Forensic Toxicology/instrumentation , Forensic Toxicology/methods , Humans , Illicit Drugs/analysis , Male , Methamphetamine/analysis , Morphine/analysis , Nordazepam/analysis , Plasma/chemistry , Predictive Value of Tests , Tandem Mass SpectrometryABSTRACT
Developing a rapid, simple, and sensitive method to analyze drugs is critical to forensic research study because of the widespread occurrence of the matrix effect. Herein, we develop a method using thermal-assisted carbon fiber ionization mass spectrometry that can be used to directly analyze drugs in biological fluid. The key feature of this technique is that the biological samples such as urine and blood can be achieved online as precipitated protein on the carbon fiber tip and thermally desorbed by the metal ceramics heater, which can reduce the matrix effects and improve the sensitivity. Analytes including raw urine, blood, oral fluid, drink, tobacco tar, drug tablets, and paper cards can be rapidly identified and analyzed within a few minutes regardless of their physical variations. Due to its simplicity and noninvasive analysis, this method can be used for drugged driving analysis and to achieve point-of-care drug testing in clinical and forensic chemistry.
Subject(s)
Body Fluids/chemistry , Forensic Medicine/methods , Mass Spectrometry/methods , Pharmaceutical Preparations/analysis , Point-of-Care Systems , Substance Abuse Detection/methods , Blood Chemical Analysis/instrumentation , Blood Chemical Analysis/methods , Carbon Fiber , Driving Under the Influence , Humans , Illicit Drugs/analysis , Substance Abuse Detection/instrumentation , Tandem Mass Spectrometry , Urinalysis/instrumentation , Urinalysis/methodsABSTRACT
The illicit drug overdose crisis in North America continues to devastate communities with fentanyl detected in the majority of illicit drug overdose deaths. The COVID-19 pandemic has heightened concerns of even greater unpredictability in the drug supplies and unprecedented rates of overdoses. Portable drug-checking technologies are increasingly being integrated within overdose prevention strategies. These emerging responses are raising new questions about which technologies to pursue and what service models can respond to the current risks and contexts. In what has been referred to as the epicenter of the overdose crisis in Canada, a multi-technology platform for drug checking is being piloted in community settings using a suite of chemical analytical methods to provide real-time harm reduction. These include infrared absorption, Raman scattering, gas chromatography with mass spectrometry, and antibody-based test strips. In this Perspective, we illustrate some advantages and challenges of using multiple techniques for the analysis of the same sample, and provide an example of a data analysis and visualization platform that can unify the presentation of the results and enable deeper analysis of the results. We also highlight the implementation of a various service models that co-exist in a research setting, with particular emphasis on the way that drug checking technicians and harm reduction workers interact with service users. Finally, we provide a description of the challenges associated with data interpretation and the communication of results to a diverse audience.
Subject(s)
Drug Overdose/diagnosis , Illicit Drugs/analysis , Substance Abuse Detection/methods , COVID-19/epidemiology , Drug Overdose/epidemiology , Gas Chromatography-Mass Spectrometry/instrumentation , Gas Chromatography-Mass Spectrometry/methods , Humans , Pilot Projects , Point-of-Care Testing , Reagent Strips/analysis , Spectrophotometry, Infrared/instrumentation , Spectrophotometry, Infrared/methods , Spectrum Analysis, Raman/instrumentation , Spectrum Analysis, Raman/methods , Substance Abuse Detection/instrumentationABSTRACT
The use of oral fluid tests to detect drugs is of growing interest in various areas, including treatment centers, roadside and workplace testing. In this study, we investigated drug detection in oral fluid samples collected using a commercially available device, Oral Eze. Drug detection in oral fluid was compared to paired urine samples, which were simultaneously collected. We also evaluated the collection device by comparing A and B oral fluid samples. Finally, we studied the stability of various drugs in samples stored for at least 1 year. The drug profile was investigated by comparing the drugs detected in oral fluid samples with paired urine samples collected in a treatment center. A total of 113 paired oral fluid and urine samples were investigated for the presence of drugs in the following groups: amphetamines, benzodiazepines, opiates and opioids, cocaine and cannabis. A and B samples were collected from different workplaces through an uncontrolled sampling procedure (n = 76). The stability of drugs in A samples was assessed after storage at -20°C for 1 year. Generally, there was a good correlation between drugs detected in oral fluid samples and urine samples. The heroin metabolite, 6-MAM, was more frequently detected in oral fluid samples than in urine samples, while cannabis was better detected in urine samples. Drugs in oral fluid samples were stable when stored at -20°C for at least 1 year. However, in many positive A and B oral fluid samples, there was significant variation in the concentrations obtained. Hence, the collection device may need to be further standardized and improved.
Subject(s)
Illicit Drugs/metabolism , Saliva/metabolism , Substance Abuse Detection/methods , Workplace , Amphetamines , Analgesics, Opioid , Benzodiazepines , Cannabis , Cocaine , Gas Chromatography-Mass Spectrometry , Humans , Illicit Drugs/analysis , Specimen Handling/instrumentation , Substance Abuse Detection/instrumentation , UrinalysisABSTRACT
Performing point-of-care urine drug screen testing at autopsy by a forensic pathologist may provide an early indication of the presence of analytes of interest during autopsy. An evaluation for the screening of 14 classes of common drugs of abuse in postmortem urine by the point-of-care screening device, Alere iCup DX 14, is presented. One hundred ninety postmortem urine samples were screened with the iCup occurring at autopsy by the forensic pathologist. Positive and negative results obtained from the screening kit were evaluated against confirmatory test results obtained using routine forensic toxicology analyses that employed LC-MS/MS and GC-MS to detect a combination of over 85 common drugs of abuse and medications. Sensitivity for each respective iCup drug class ranged from 66% (buprenorphine) to 100% (methadone, tricyclic antidepressants). Specificity for each respective iCup drug class ranged from 89% (benzodiazepines) to 100% (amphetamines, barbiturates, buprenorphine, 3,4-methylenedioxymethamphetamine, methadone). Positive predictive values ranged from 44% (benzodiazepines) to 100% (amphetamines, barbiturates, buprenorphine, methylenedioxymethamphetamine, methadone), while negative predictive values ranged from 96% (methamphetamine) to 100% (barbiturates, methadone, tricyclic antidepressants). A high false-positive rate was yielded by the benzodiazepine class. The lack of fentanyl screening in the point-of-care device is a significant limitation considering its prolific prevalence in forensic casework. The results obtained in the study should be acknowledged when considering the use of the Alere iCup DX 14 in the context of postmortem casework to help indicate potential drug use contemporaneously with autopsy and when requiring such preliminary results prior to the release of a final forensic toxicology report.
Subject(s)
Forensic Toxicology/instrumentation , Illicit Drugs/urine , Pharmaceutical Preparations/urine , Point-of-Care Systems , Substance Abuse Detection/instrumentation , Autopsy , Chromatography, Liquid , Gas Chromatography-Mass Spectrometry , Humans , Predictive Value of Tests , Sensitivity and Specificity , Tandem Mass SpectrometryABSTRACT
This trend article reviews papers with hyphenated high-resolution mass spectrometry (HRMS) approaches applied in analytical toxicology, particularly in clinical and forensic toxicology published since 2016 and referenced in PubMed. The article focuses on the question of whether HRMS has or will become the all-in-one device in these fields as supposed by the increasing number of HRMS presentations at scientific meetings, corresponding original papers, and review articles. Typical examples for the different application fields are discussed such as targeted or untargeted drug screening, quantification, drug metabolism studies, and metabolomics approaches. Considering the reviewed papers, HRMS is currently the only technique that fulfills the criteria of an all-in-one device for the various applications needed in analytical toxicology.Graphical abstract.
Subject(s)
Forensic Toxicology/methods , Mass Spectrometry/methods , Animals , Forensic Toxicology/instrumentation , Humans , Mass Spectrometry/instrumentation , Metabolomics/instrumentation , Metabolomics/methods , Pharmaceutical Preparations/analysis , Pharmaceutical Preparations/metabolism , Substance Abuse Detection/instrumentation , Substance Abuse Detection/methodsABSTRACT
INTRODUCTION: Crashes involving drinking drivers represent as much as one-third of all fatal crashes around the world. Progress has been made in reducing this toll through a series of interventions that attempt to discourage driving while intoxicated (DWI) and reoffending among drivers who have been convicted of DWI. However, these approaches cannot eliminate the problem. In-vehicle technologies are being developed, such as the Driver Alcohol Detection System for Safety-commonly referred to as DADSS-that have the potential to prevent alcohol-impaired drivers from driving their vehicles. DADSS in-vehicle sensors are designed to quickly detect whether drivers have been drinking and accurately and precisely measure blood or breath alcohol concentration. If the driver's alcohol concentration measures at or above a set limit, the vehicle will be prevented from moving. METHOD: The DADSS technology is expected to be ready for real-world applications in the next few years. The implementation of this technology in vehicles promises to prevent thousands of deaths and injuries every year. This paper investigates approaches that have been used in various countries to accelerate the deployment of innovative vehicle safety technologies beginning with its initial implementation in vehicles through to its more widespread use. RESULTS: Various approaches were identified that can smooth and accelerate the deployment of in-vehicle alcohol detection devices. Recommendations are made regarding the most promising approaches to use initially and over time, as the body of evidence regarding their effectiveness grows. CONCLUSIONS: This paper provides guidelines for how best to stimulate the widespread adoption of in-vehicle alcohol-detection technology as a preventive measure so that its life-saving potential can be realized both in the United States and in other countries that may be open to the implementation of DADSS.
Subject(s)
Accidents, Traffic/prevention & control , Driving Under the Influence/prevention & control , Ethanol , Motor Vehicles , Substance Abuse Detection/instrumentation , Accidents, Traffic/mortality , Breath Tests , Driving Under the Influence/legislation & jurisprudence , Ethanol/analysis , Ethanol/blood , Humans , United States/epidemiologyABSTRACT
The perspective discusses quantitative DBS analysis for anti-doping testing in an athletic population and why only using volumetric sampling for this subgroup might not be enough. It presents examples to highlight where HCT variations occur, followed by a whole blood to plasma ratio and an HCT extraction bias discussion. Finally, options to correct for the HCT bias are presented.
Subject(s)
Dried Blood Spot Testing/methods , Hematocrit/methods , Substance Abuse Detection/methods , Doping in Sports , Dried Blood Spot Testing/instrumentation , Equipment Design , Hematocrit/instrumentation , Humans , Substance Abuse Detection/instrumentationABSTRACT
OBJECTIVES: The objective of this study was to estimate the number of crash deaths specifically attributable to alcohol-impaired driving, with a focus on various strategies for introducing vehicle-based solutions. If alcohol detection systems are standard in all new vehicles, how many lives could be saved in the near term, and how long will it take to essentially eliminate alcohol-impaired driving? Alternatively, if such systems are offered as an option, how many lives could be saved? METHODS: Fatal crashes in the United States during 2015-2018 were classified by the highest driver blood alcohol concentration (BAC) and the corresponding age category of that driver. Based on the estimates of relative risk (RR) for a given driver group, eliminating alcohol in the driver's blood should lower risk by the attributable proportion, 1 - 1/RR. Multiplying this quantity by the number of deaths for the driver group yielded the estimated number of lives potentially saved if the BACs were reduced to zero. RESULTS: Systems that restrict drivers with any BAC could prevent nearly 12,000 deaths per year, while systems that restrict BAC to less than 0.08 g/dL could prevent more than 9,000 deaths. Within 3 years of a mandate for vehicle-based alcohol detection systems, it is expected that the annual lives saved would be between 1,000 and 1,300. Within 6 years, it would be between 2,000 and 2,600 lives saved per year, and within 12 years it would be between 4,600 and 5,900 lives saved per year. A system required only for those convicted of alcohol-impaired driving could save between 800 and 1,000 lives per year. A system available only to fleets of vehicles could save between 300 and 500 lives per year. CONCLUSIONS: Vehicle-based interventions will not immediately solve the problem of alcohol-impaired driving, but they are an important component of the overall strategy. Even if required as standard equipment in all new vehicles, it will take 12 years before there are enough to reach more than half of their potential. If vehicle-based interventions are instead voluntary or introduced as options, then progress toward a solution will be much slower.
Subject(s)
Accidents, Traffic/mortality , Driving Under the Influence/prevention & control , Ethanol , Motor Vehicles , Substance Abuse Detection/instrumentation , Adolescent , Adult , Blood Alcohol Content , Ethanol/blood , Humans , Risk , United States/epidemiology , Young AdultABSTRACT
In this paper, a low-cost, rapid, easy, and potentially portable tool for the identification of cocaine and its semi-quantitative determination in oral fluid has been proposed. A field collection device has been designed, based on a cotton pad with an indicator and a molecularly imprinted polymer (MIP) sorbent, to selective retain cocaine from oral fluid components. After sample collection, cocaine is transferred by using phosphate buffer to the MIP and then eluted with 2-propanol. The obtained extract is analysed by ion mobility spectrometry (IMS), providing a cut-off value of 20 µg L-1 that identifies 100 % true-positive and 95 % true-negative samples. The MIP-IMS procedure has been validated by the analysis of oral fluid samples, collected from cocaine users at recreation environments, by comparing the results with lateral flow immunoassay and chromatographic reference methods. Thus, the proposed methodology allows a simple and fast cocaine identification that can be carried out in field by non-specialized personnel, such as health personnel, law enforcement bodies, and customs staff.
Subject(s)
Cocaine/analysis , Molecular Imprinting , Saliva/chemistry , Substance Abuse Detection/instrumentation , Substance Abuse Detection/methods , Humans , Ion Mobility Spectrometry , Polymers/chemistryABSTRACT
A study of impaired driving rates in the province of Québec is currently planned following the legalization of recreational cannabis in Canada. Oral fluid (OF) samples are to be collected with a Quantisal® device and sent to the laboratory for analysis. In order to prepare for this project, a qualitative decision point analysis method monitoring for the presence of 97 drugs and metabolites in OF was developed and validated. This high throughput method uses incubation with a precipitation solvent (acetone:acetonitrile 30:70 v:v) to boost drug recovery from the collecting device and improve stability of benzodiazepines (e.g., α-hydroxyalprazolam, clonazepam, 7-aminoclonazepam, flunitrazepam, 7-aminoflunitrazepam, N-desmethylflunitrazepam, nitrazepam). The Quantisal® device has polyglycol in its stabilizing buffer, but timed use of the mass spectrometer waste valve proved sufficient to avoid the glycol interferences for nearly all analytes. Interferences from OF matrices and 140 potentially interfering compounds, carryover, ion ratios, stability, recovery, reproducibility, robustness, false positive rate, false negative rate, selectivity, sensitivity and reliability rates were tested in the validation process. Five of the targeted analytes (olanzapine, oxazepam, 7-aminoclonazepam, flunitrazepam and nitrazepam) did not meet the set validation criteria but will be monitored for identification purposes (no comparison to a cut-off level). Blind internal proficiency testing was performed, where six OF samples were tested and analytes were classified as "negative", "likely positive" or "positive" with success. The final validated OF qualitative decision point method covers 92 analytes, and the presence of 5 additional analytes is screened in this high throughput analysis.